Table 2 Insulin sensitivity, glucose and lipid oxidation, and non-oxidative glucose metabolism in the study groups

From: Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation

 

Lean group (n=42)

Obese group (n=42)

M (mg kg−1 FFM per min)

10.43±3.56

7.06±3.56*

REE—basal (kcal per day)

1520.5±283.9

1897.9±283.3*

REE—clamp (kcal per day)

1611.3±265.8

1788.3±220.8*

GOx—basal (mg kg−1 FFM per min)

1.42±0.85

1.36±0.89

GOx—clamp (mg kg−1 FFM per min)

2.34±0.94

1.65±1.05*

LOx—basal (mg kg−1 FFM per min)

1.05±0.35

1.27±0.49*

LOx—clamp (mg kg−1 FFM per min)

0.83±0.46

1.12±0.51*

ΔRQ

0.05±0.06

0.02±0.05*

NOGM (mg kg−1 FFM per min)

7.90±3.59

5.47±3.50*

  1. Abbreviations: FFM, fat-free mass; GOx, glucose oxidation; LOx, lipid oxidation; NOGM, non-oxidative glucose metabolism; REE, resting energy expenditure; RQ, respiratory quotient.
  2. *P<0.05.
Back to article page